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ABSTRACT
Autophagy is a well-conserved process of self-digestion of intracellular components. T. cruzi is
a protozoan parasite with a complex life-cycle that involves insect vectors and mammalian hosts.
Like other eukaryotic organisms, T. cruzi possesses an autophagic pathway that is activated during
metacyclogenesis, the process that generates the infective forms of parasites. In addition, it has
been demonstrated that mammalian autophagy has a role during host cell invasion by T. cruzi,
and that T. cruzi can modulate this process to its own benefit. This review describes the latest
findings concerning the participation of autophagy in both the T. cruzi differentiation processes
and during the interaction of parasites within the host cells. Data to date suggest parasite
autophagy is important for parasite survival and differentiation, which offers interesting prospects
for therapeutic strategies. Additionally, the interruption of mammalian autophagy reduces the
parasite infectivity, interfering with the intracellular cycle of T. cruzi inside the host. However, the
impact on other stages of development, such as the intracellular replication of parasites is still not
clearly understood. Further studies in this matter are necessaries to define the integral effect of
autophagy on T. cruzi infection with both in vitro and in vivo approaches.
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Introduction
Successful parasites have evolved to live and develop in
specific hosts during their biological cycle. They have
accumulated adaptations in response to environmental
changes such as the immune response of the host. The
repetition of the parasite-host interaction cycle ensures
the persistence of several species of parasites. In
humans, this interaction causes health disorders
known as vector-borne and parasitic diseases.
According to the WHO, human parasitic diseases
cause more than 700,000 deaths each year (http://
www.who.int/vector-control/en/). These infectious
diseases are caused by parasites from the group of
protozoa and helminths. Some species of arthropods
are also parasites and produce the so-called ectopar-
asitic diseases. Many of these diseases are classified as
Neglected Tropical Diseases (NTDs) because they are
caused by pathogens present in tropical and sub-
tropical areas, and are often overlooked by pharma-
ceutical companies and even the public health
community.
Trypanosomatidae is a vast family of protozoan
parasites characterized by the presence of a single fla-
gellum and a compacted DNA called kinetoplast. All
members are exclusively parasitic, found primarily in
insects. A few genera have life-cycles involving
a secondary host, which may be a vertebrate, inverte-
brate or plant. These include several species that cause
major diseases in humans [1]. The three major human
diseases caused by trypanosomatids are Leishmaniasis,
caused by various species of the genus Leishmania;
African trypanosomiasis (or “sleeping sickness”),
caused by Trypanosoma brucei; and American trypano-
somiasis or Chagas disease, caused by Trypanosoma
cruzi. These digenetic parasites have complex biological
cycles in response to the specific adaptations required
to live within two very different types of hosts, the
insect vector and the mammalian organism.
Autophagy is an intracellular catabolic pathway highly
conserved in eukaryotic organisms. Experimental and
genomic data showed that the autophagymachinery char-
acterized in animals and fungi also appeared in protists
and function for diverse lifestyle adaptations [2].
Pathogenic protists can either utilize their own autophagy
mechanisms or manipulate host-cell autophagy in order
to establish or maintain infection within a host. This work
revises the involvement of T. cruzi and host cell autop-
hagy during the T. cruzi life-cycle.
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The T. cruzi life-cycle and the infection process
During its complex life cycle, T. cruzi is found in three
different parasitic forms. Epimastigotes and amastigotes
are the replicative stages found in the lumen of the
intestine of triatomine insect vectors or in the cytosol
of infected host cells, respectively. The infective forms
of T. cruzi are metacyclic trypomastigotes and blood-
stream trypomastigotes, derived from epimastigotes
and amastigotes, respectively, both with the capacity
to invade a large number of different cell types in
a process independent of host cell actin polymerization
[3]. The so-called extracellular amastigotes, originated
from the premature rupture of infected cells or trans-
formed from swimming trypomastigotes, are also infec-
tive forms that, in contrast to trypomastigotes, require
functional intact microfilaments to infect non-
phagocytic host cells [4,5].
The T. cruzi entry process was classically divided into
two specific steps (Figure 1, points 1 and 2): the adhe-
sion process, related to the binding of T. cruzi antigens
to host cell receptors which trigger cell signaling events
[6,7]; and the internalization process that describes the
mechanism that culminates in the formation of the
T. cruzi parasitophorous vacuole (TcPV). Adhesion of
trypomastigotes is driven by a repertoire of molecules
present at the parasite surface or secreted during the
infection process which bind to the specific receptors
in the host cells [6,8,9]. Despite the advances made
towards identification of the receptor molecule respon-
sible for the adhesion of parasites, no single main host
receptor candidate has been identified yet. In fact, the
arsenal of parasite surface proteins and the multiple
possible host receptors provide several opportunities
for T. cruzi to recognize and contact cells and explains
why this parasite is able to infect almost all types of
mammalian cells [10,11]. The adhesion to cell surface
triggers a host cell signaling cascade that culminates in
the formation of the T. cruzi parasitophorous vacuole.
Different processes have been described for the interna-
lization of T. cruzi into non-phagocytic cells. Seminal
studies showed two different models of trypomastigote
invasion: by activating the lysosomal exocytosis or by
inducing an endocytosis-like process. Both agree on the
absence of plasma membrane protrusions (and micro-
filaments) but differ in the source of the membrane that
initially envelops the parasite. The first model demon-
strated that parasites elicited a Ca2+ signaling cascade in
the host cells which activates lysosomal exocytosis [12].
The later fusion of lysosomes with the host plasma
membrane allows the parasite entry and the formation
of a parasitophorous vacuole with lysosomal character-
istics [13]. This lysosomal exocytosis is produced with
the peripheral pool of lysosomes and require microtu-
bules and kinesin to the lysosomal transport toward the
plasma membrane [14,15]. Autophagy has also been
shown to participate in this process by the finding of
autophagic proteins in the TcPV membrane [16] (see
below). In contrast, the endocytosis-like process claims
that at very early times after infection, the highest pro-
portion of trypomastigotes enter host cells by invagina-
tion of the plasma membrane that generates an initial
TcPV enriched in phosphoinositides derived from
plasma membrane but not lysosomal markers [17].
This model reinforced previously published data that
demonstrated the participation of endocytic GTPases
such as Rab5 and Rab7 and dynamin in the T. cruzi
infection process [18,19]. Later studies showed that
T. cruzi exploited the plasma membrane wound repair
mechanism [20] carried out by the exocytosis of lyso-
somes at the site of the injury followed by the compen-
satory endocytosis of injured membranes [21]. In
summary, both events, exocytosis and endocytosis, pre-
viously classified as independent processes, now, under
the light of these new data, have been shown to occur
sequentially during parasite invasion. The different styles
of T. cruzi entry were also associated with the different
trypomastigote forms. Metacyclic trypomastigotes (MT)
that express gp82, the surface molecule that mediates
invasion, induce mTOR dephosphorylation and lyso-
some biogenesis and scattering, evidencing preferentially
the lysosomal exocytosis process. In contrast, the entry
of tissue culture trypomastigotes (TCT), the equivalent
to blood-stream trypomastigotes, is predominantly
related to endocytosis [22]. Other forms of T. cruzi
entry into host cells, such as phagocytosis and macro-
pinocytosis, have been also described [23].
In addition to the specific manner of TcPV formation,
there is a third little described step during T. cruzi invasion
that involves the TcPV maturation (Figure 1, point 3).
Fusion of lysosomeswith the early parasitophorous vacuole
is crucial to the progress of infection. Previous works from
the laboratory of Norma Andrews have demonstrated that
when lysosomal fusion was inhibited, internalized parasites
failed to be retained inside host cells and escaped to the
extracellular environment [24,25]. The abolition of this
phenomenon, known as reversal infection, by allowing
the lysosomal fusion to TcPV, is a key process for the
retention of T. cruzi inside the host cell [26]. In agreement
with this, further studies from our group demonstrated
that the SNARE VAMP7 and its partner Vti1b, both com-
ponents of the molecular machinery that promotes lysoso-
mal fusion, are required during T. cruzi vacuole
development and, as a consequence, for the parasite infec-
tion [27]. We have also shown that migration of VAMP7
positive vesicles to the TcPV depends on KIF5, a motor
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protein belonging to the superfamily of kinesins. It was
suggested that the highly motile trypomastigotes contained
in vacuoles fail to associate with microtubules when lyso-
somal fusion is impaired, allowing the parasites to continue
to move around the cytosol and eventually leave the cell. In
the same way, the loss of parasite motility associated with
the lysosomal fusion to the TcPV could be attributed to the
beginning of the differentiation process from trypomasti-
gotes to non-motile amastigotes induced in part by the
acidic pH gained by the vacuole during this process. The
striking morphological transition undergone by the para-
site throughout the course of the infection process, from
the typical elongated form at early times to the ovoid form
at later times [27] strengthens this idea. Maturation of the
vacuole is finally a key process for both the retention of
T. cruzi inside the host cell and for the progression of the
T. cruzi intracellular cycle by allowing the differentiation
from trypomastigotes to amastigotes.
The autophagic pathway
Autophagy is a catabolic pathway conserved in most
eukaryotes from yeast to mammalian cells [28]. This
process involves the cellular self-digestion through the
lysosomal machinery. Macroautophagy, the most widely
studied type of autophagy, is important in many physio-
logical situations such as cell development, cell growth,
and cell differentiation. As a constitutive process,
autophagy functions at basal levels in the turnover of
long-lived proteins and old organelles for maintaining
cellular homeostasis. Nutritional stress conditions are
the main physiologic stimulus of autophagy. Under
these situations, cells entrap cytoplasmic materials and
degrade them to provide aminoacids that function as
energy source for cell survival [29]. Besides this bulk
degradation process, autophagy functions selectively to
remove misfolded or aggregated proteins, damaged orga-
nelles, such as mitochondria, endoplasmic reticulum and
peroxisomes, as well as to eliminate intracellular patho-
gens, being part of the innate immune response [30]. The
autophagic pathway involves specific compartments
inside the cell. Basically, the cytoplasmic cargo is captured
through the intermediary of a double membrane-bound
vesicle, referred to as autophagosome, which fuses with
the lysosome to form an autolysosome. In mammalian
cells, autophagosomes derived from an isolation mem-
brane, also known as phagophore, which is likely derived
from a lipid bilayer contributed by the endoplasmic reti-
culum and/or the trans-Golgi and late endosomes [31–
33]. The outer mitochondrial membrane and the plasma
membrane can also participate as membrane donor [34];
therefore, the exact origin of the phagophore in mamma-
lian cells is still controversial. The isolation membrane
grows around the cargo and finally closes to form the
early autophagosome, easily recognized as a double-
membrane vesicle by electron microscopy [35].
Lysosome
Inmature TcPV
Mature TcPV
1
2 3
Figure 1. The three steps of the T. cruzi invasion. The scheme summarizes the process of T. cruzi entry into the host cell. (1) Adhesion
of trypomastigotes to the host cell surface. (2) Internalization of trypomastigotes produced by invagination of the plasma
membrane. (3) Vacuole maturation proceeds after the fusion with lysosomes which initiates the differentiation of T. cruzi from
trypomastigotes to amastigotes.
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Autophagosomes can then fuse with endocytic compart-
ments to form amphisomes, which, in turn, fuse with
lysosomes, forming autolysosomes where the proteins
are degraded to amino acids that are recycled via lysoso-
mal permeases and other transporters [36].
Specific molecules coordinate this complex process. To
date, different autophagy-related genes (Atg) have been
identified by genetic screening in yeast [28]. Many of
them have been conserved in mammalian cells. These
genes can be grouped according to their functions at key
stages of the autophagy pathway: initiation, elongation,
maturation, and fusion with the lysosomes. In mammalian
systems, the phagophore is derived from membranes
enriched in phosphatidyl inositol triphosphate (PI3P), the
product of the Beclin1-Vps34 complex [37]. Phagophore
elongation requires the sequential activation of two protein
conjugation reactions. The mammalian Atg5-Atg12-Atg
16L complex is recruited to the isolation membrane, favor-
ing the extension of the precursormembrane [38]. LC3, the
mammalian homolog of Atg8, is then conjugated with
phosphatidylethanolamine (PE) to form LC3-II, which
inserts into the autophagosomemembrane and contributes
to vesicle elongation [39]. After autophagic induction LC3-
II is visualized by a punctuate pattern corresponding to
autophagic vesicles. Unlike the Atg5-Atg12.Atg16L com-
plex, LC3-II remains on completed autophagosomes and
also on autolysosomes [40]. The final steps of autophagy
involve docking and fusion of autophagosomes to lyso-
somes to generate autolysosomes which produce cargo
degradation and recycling. Specific Rab GTPases and
SNAREs proteins function as master regulators of these
fusion events. Impairment of this process by the use of
mutant proteins or chemicals prevents the normal matura-
tion of the pathway leading to the accumulation of autop-
hagosomes. Bafilomycin A1 is a broadly used autophagic
flux inhibitor that prevents the fusion of autophagosomes
with endosomes/lysosomes and the autophagic degrada-
tion [41].
Two key signaling processes converge to correlate
canonical autophagy with cell nutrient or stress condi-
tions, the mTOR and the PI3K pathways. The mTOR
signaling cascade transduces the response from growth
factors, via class I PI3K, Akt/PKB, and so forth, to nega-
tively regulate autophagy [42]. Rapamycin is one of the
classical inducers of autophagy due to inhibition of the
mTOR signaling pathway [43]. As mentioned above,
Beclin1-Vps34 complex is necessary to produce the PI3P
required in the phagophore formation and elongation.
This class III PI3K complex is inhibited by wortmannin,
which blocks the autophagosome initiation process [44].
The process of autophagy can be monitored intracellu-
larly by utilizing LC3 fused to a fluorescent protein such as
GFP-LC3 or mCherry-LC3. Fluorescent LC3 is
incorporated into the autophagosomes and could be
observed as small dots inside the cell by light microscopy.
The number of puncta in a cell at any specific time is
a function of both the formation and the clearance of
autophagosomes [45].
Selective autophagy refers to the different mechanisms
of capture and degradation of specific cargos by autop-
hagy. These non-canonical classes of autophagy are
named according to the type of component that has
been incorporated to the route, such as mitophagy, pex-
ophagy and xenophagy [46], among others. Xenophagy is
the process by which cells can degrade an intracellular
microorganism present inside a phagosome [47,48] or
free in the cytosol [49]. Due to this property, xenophagy
has been classified as a component of the innate immune
responses against intracellular pathogens. Xenophagy
generally functions as a second barrier when phagocytosis
or other defense mechanisms are exceeded. However,
some pathogens have the capacity to evade autophagic
responses or to subvert the autophagic pathway and to
live and replicate inside an autophagosomal compartment
(see below). Recent research has related LC3 protein to
pathways other than autophagy. Since 2007, the concept
of LAP (LC3-associated phagocytosis) has been intro-
duced. Nowadays LAP is understood as a type of non-
canonical autophagy. LAP uses some autophagic compo-
nents but it differs mainly in that the LC3 positive vesicle
is a simple membrane compartment [50,51].
Autophagy during the T. cruzi life-cycle
As eukaryotic organisms, protists possess a rudimentary
autophagic pathway that functions at specific stages of their
life-cycles mainly during the differentiation processes [2].
Autophagy is also activated when pathogenic protists are
treated with anti-parasitic drugs, as a mechanism to over-
come the stress caused by the toxic compounds before cell
death [52–55]. In addition, a growing body of evidence
shows that intracellular protists have the ability to manip-
ulate host-cell autophagy in order to establish or maintain
the infection within a host. Below we summarize the find-
ings made on the T. cruzi autophagy pathway and its
participation in the differentiation processes, and then we
describe the recent advances concerning the interaction of
T. cruzi with host cell autophagy.
Autophagy is induced during the T. cruzi
differentiation processes
The first evidence for the existence of an autophagic-like
process in T. cruzi was provided, as in mammalian cells,
by morphological studies showing the presence of dou-
ble-membrane vesicles and multivesicular structures in
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parasites treated with trypanocidal drugs [56,57]. Later
genome database searches supplemented with more
advanced analyses revealed the presence of autophagy-
associated components in T. cruzi [58–60]. These bioin-
formatics analyses showed that only half of the genes
found in yeasts were present in trypanosomatids.
T. cruzi possesses all components of the LC3/Atg8 con-
jugation system, but lacks the Atg5-Atg12 protein com-
plex, indicative of a different manner to initiate and
elongate the autophagosome. Two TcAtg8 homologs
have been found in T. cruzi: TcAtg8.1 and TcAtg8.2.
Only the first one was functionally linked to autophagy
[60]. During starvation, TcAtg8.1 is efficiently cleaved by
one of the two TcAtg4 homologs (autophagins) and
then, after conjugation to PE, is inserted in the mem-
brane of the autophagosome-like vesicles [60]. Further
studies from our lab established the participation of
autophagy during the differentiation of T. cruzi from
epimastigotes to metacyclic trypomastigotes [61]. This
process, called metacyclogenesis, takes place in the
lumen of the intestine of the triatomine vector. The
reduced nutrient availability produced by the high multi-
plication of epimastigotes is the main stimulus to induce
it. By performing an in vitro method of differentiation,
we showed an increment in the number of Atg8.1 posi-
tive vesicles during starvation. The same result was
observed in the presence of other autophagy inducers
such as rapamycin, the classical inhibitor of TOR kinase,
and spermidine, a polyamine that induces autophagy in
many eukaryotic organisms by regulation of gene
expression and protein activity [62]. We also showed
that classical autophagy inhibitors such as wortmannin
impaired the autophagosome formation in T. cruzi [61].
In agreement with this, Schoijet et al. [63] showed that
TcVps34 kinase (the parasitic counterpart of the mam-
malian Beclin-1-Vps34 kinase) is regulated by TcVps15
and that both form a complex that participates in starva-
tion induced autophagy in T. cruzi. As mentioned above,
bafilomycin is a H+ pump inhibitor that impairs the
normal autophagic flux, producing an accumulation of
autophagic structures [41]. In contrast to mammalian
cells, in T. cruzi bafilomycin inhibits the first steps of
autophagy, evidenced by the low number of Atg8.1
positive vesicles generated under this treatment.
A previous work showed that formation of autophago-
some in the related parasite T. brucei requires the nor-
mal acidification of acidocalcisomes, acidic parasitic
compartments required for osmoregulation [64].
Acidification impairment of acidocalcisomes by bafilo-
mycin treatment completely abrogates autophagic
response, indicating that these compartments could be
participating in the first steps of autophagy in trypano-
somes in a not yet clearly understood mechanism.
Autophagy is also required during the differentiation
of trypomastigotes to amastigotes, a process that starts
in the acidic environment of the parasitophorous
vacuole and finish in the host cell cytosol. Our previous
data showed that starvation in PBS and rapamycin were
able to induce this process similarly to low pH.
Moreover, we observed Atg8-decorated vesicles in
amastigotes present in the cytosol of infected cells,
indicating that autophagy can be induced in the para-
site inside the host [16]. Although more studies will be
necessary in the future to elucidate the specific mechan-
isms that regulate autophagy in trypanosomatids, these
data show that this process is an interesting target to be
modulated to impair T. cruzi survival in the host.
Host autophagy during T. cruzi infection
Invasion of trypomastigotes
As mentioned above, the interaction between host autop-
hagy and intracellular pathogens has different fates accord-
ing to the type of microorganism and host cells. Many
microorganisms can be engulfed by autophagic compart-
ments and eliminated in an autolysosome by xenophagy.
Another group of pathogens has the ability to subvert the
autophagic pathway to its own benefit. Some pathogens
inhibit the autophagic flux to replicate in an autophagic
nichewhich does not fuse with lysosomes [65]. Others have
evolved to live and replicate inside a compartment with
autolysosomal characteristics [66–69]. In the case of
T. cruzi, our data showed that this parasite exploits autop-
hagy to support invasion of the host cell. Previous studies
from our laboratory demonstrated that parasite entry by
the lysosomal route is favored under conditions that
increase autophagy [16,70]. Induction of autophagy before
infection by starvation or other means significantly
increased the percentage of infected cells by enhancing
the number of lysosomal compartments (lysosomes and
autolysosomes) available for T. cruzi infection, resulting in
an increased colonization of the host cell. We also showed
that the T. cruzi parasitophorous vacuole is decorated with
LC3 protein (Figure 2) and that the autophagic inhibitors
wortmannin, 3-methyladenine or vinblastine suppress this
recruitment and also significantly reduce the intracellular
infection. Interestingly, infection was diminished in the
absence of specific autophagy genes Beclin1 or Atg5,
which are required for initiation of autophagy, indicating
that autophagic-derived compartments are required for the
increased entry of T. cruzi into the host cell. The pro-
pathogen effects of autophagy on T. cruzi infection were
observed in different types of host cells and of T. cruzi
strains, demonstrating that this interaction is a widespread
phenomenon [71]. These data were obtained with the TCT
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forms ofT. cruzi. Quite different features were described by
the group of Nobuko Yoshida, working with metacyclic
trypomastigotes. They showed that, in contrast to TCT,
pre-starvation of cells by 2 h or rapamycin treatment
reduced MT invasion whereas other conditions that pro-
mote lysosomal exocytosis increased it [72]. Further data
from the same group demonstrated that conditions that
promote lysosome biogenesis and scattering such us 1 h
starvation or treatment with sucrose, increase cell suscept-
ibility to MT and resistance to TCT [22]. Due to cellular
distribution of lysosomes have different outcomes related
to the treatment used (1 h or 2 h starvation or rapamycin),
these data indicate that MT invasion is mainly related to
lysosomal exocytosis, whereas TCT entry is predominantly
an endocytosis–like process.
Concerning the mechanism of T. cruzi invasion, it is
important to note that, as mentioned above, a growing
body of evidence showed that trypomastigotes exploit
the lysosome-dependent membrane repair mechanism
to enter the host cell [21]. In this sense, autophagy has
been shown to play a role in the fixing of damaged
pathogen containing vacuoles such as Salmonella [73].
The rupture of the cell surface produced by T. cruzi
during invasion may trigger the autophagic response as
a mechanism to restore the plasma membrane integrity.
In agreement with this hypothesis, our results using live
imaging by confocal microscopy showed that GFP-LC3
positive vesicles move towards the plasma membrane
and contact the sites where trypomastigotes bind to the
membrane [16,71].
A recent work showed that autophagosome forma-
tion was induced by T. cruzi infection. By quantifying
the number of LC3 puncta in cells infected with
T. cruzi, the authors demonstrated a gradual increment
of these vesicles, which reach a maximum level at 9 h
post infection [74]. Unpublished data from our labora-
tory show that the percentage of cells with more than
five LC3-positive vesicles/cell was significantly
increased in cells infected with TCT of T. cruzi
Y strain, compared to control (Figure 2). Interestingly,
we also observed a significantly higher number of LC3-
positive tubules in these cells, which has not been
observed either in the uninfected control cells or in
rapamycin treated cells (Figure 2). Some of these
tubules are even associated with the TcPV. Previous
works have associated this type of dynamic tubules
with efficient pathogen proliferation [75,76].
Induction of these tubules in cells infected with
T. cruzi could favor the arrival or elimination of spe-
cific molecules into the TcPV, creating a favorable
niche for the parasite. More experiments will need to
confirm this hypothesis.
Onisuka and colleagues [74] also showed that
T. cruzi infection inhibited the normal maturation of
autophagosomes to autolysosomes (autophagic flux).
Our investigation concerning this point was not con-
clusive. By using the GFP-RFP-LC3 tandem, we did not
observe a different pattern of green and red colocaliza-
tion, compared to control. Western blot experiments
also yielded the same ambiguous results (data not
shown). Unexpectedly, colocalization between DQ-
BSA, one of the best markers of hydrolytic compart-
ments, with the T. cruzi vacuole at different times after
infection was lower compared to the marker of acidic
compartments lysosensor (data not shown). On the
other hand, many authors, including our laboratory,
Figure 2. Autophagy is induced during T. cruzi infection. CHO cells overexpressing GFP-LC3 were infected with tissue culture
trypomastigotes (TCT) of T. cruzi Y strain (MOI = 50) during 3 h. After fixation, cells were washed, mounted in mowiol and analyzed
by confocal microscopy. (a) Control (non-infected) cells depicting the homogeneous distribution of GFP-LC3 in the soluble form. (b)
Infected cell displaying numerous autophagic vacuoles and tubules (arrows) decorated with membrane-associated GFP-LC3. Note
the recruitment of this protein in the membrane of the T. cruzi parasitophorous vacuole (asterisks) that were recognized by the
typical form of trypomastigotes. (c) Percentage of cells containing more than 5 LC3-positive vesicles/cell and at least one tubule/cell
at the indicated conditions. Rapamycin (50 ng/μl) were incubated for 2 h in control conditions. Scale bar: 5 μm. Data shown
represent the mean ± SE from 3 independent experiments. *p < 0.05, ***p < 0.001 (Student´s t-test).
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found the classical late endosomal/lysosomal markers,
such as VAMP7, Lamp 1 and 2 and Cathepsin D, in the
TcPV by indirect immunofluorescence [13,16,27].
These evidences suggest that although lysosomal fusion
to TcPV is produced during vacuole maturation, the
final mature TcPV might not be as hydrolytic as sup-
posed. If this is the case, lysosomal enzymes might not
be fully delivered to the vacuole or remain with low
activity inside de TcPV because of the sub-optimal pH.
Another possibility is that lysosomal enzymes were not
activated inside the TcPV by a currently unknown
mechanism. This hypothesis may explain, in addition
to other mechanisms, the resistance of the parasites to
lysosomal degradation. More studies will be necessary
to confirm this assumption.
Intracellular differentiation and replication of
amastigotes
As mentioned above, previous studies from our labora-
tory showed that conditions that increase autophagy
favor the differentiation in vitro from trypomastigotes
to amastigotes [16]. Atg8 positive vesicles were also
visualized in amastigotes developed in the host cells
[16]. Although more studies will need to confirm
these findings, these evidences suggest the participation
of autophagy in the T. cruzi intracellular differentiation.
The following stage in the T. cruzi intracellular cycle,
the proliferation of amastigotes, was not significantly
impacted by the autophagic modulation in non-
phagocytic host cells, compared to cells maintained in
control conditions [16]. Since T. cruzi has its own
autophagic pathway that can be modulated by the
same inducers and inhibitors of host autophagy [61],
other experimental approaches will be necessary to
decipher the possible action of autophagy modulation
on T. cruzi infected cells. In this context, autophagy-
deficient host cell lines can be used to specifically assess
the impact of host autophagy loss. In contrast, growth
of amastigotes on professional phagocytes might be
affected by the autophagic response of these cells as it
is described in the following section.
Autophagy on in vivo models of infection
To date there is not published data about the outcome of
T. cruzi infection in vivo under autophagic modulation.
The pathogen/autophagy relationship on models of mur-
ine infections, with the exception of a few cases, remains
little understood. The effect of autophagy as an innate
immune component is easier to understand, particularly
with the use of knockout mice. Studies onM. tuberculosis
murine infections showed that Atg5 deficient mice
relative to autophagy-proficient littermates resulted in
increased bacillary burden and excessive pulmonary
inflammation evidencing the role of autophagy in vivo
by suppressing both M. tuberculosis growth and dama-
ging inflammation [77]. Furthermore, mice deficient in
either IFN-γ or IFN-γ receptors are highly susceptible
to M. tuberculosis infection [78]. It is known that IFN-γ
is a key cytokine in the regulation of the immune
responses [79] that explains the high susceptibility of
these mice to mycobacterial infection. This cytokine is
also a strong inducer of autophagy in macrophages [80].
Taking into account that macrophage activation is a key
process to controlM. tuberculosis infection, the absence of
an appropriate autophagy/xenophagy response from
macrophages might also explain the higher bacterial bur-
den observed in these mice.
The main concerns with the in vivo models arise
from the cases of pathogens for which in vitro stu-
dies have shown them to be favored by autophagy
induction. No current evidence demonstrates that
autophagy gene deletion in the host attenuates
microbial disease in these cases. Therefore, the phy-
siological significance of microbial utilization of
autophagy for “promicrobial” effects remains to be
established [81]. In line with these thoughts, our
group observed a more aggressive infection of
T. cruzi in an autophagy deficient mice model com-
pared to the wild type counterpart (Casassa et al,
unpublished). We also observed higher levels of
infection in peritoneal cells obtained from autop-
hagy deficient mice than cells from control animals.
This means that contrary to what was observed on
in vitro infections, deficiency of autophagy on
in vivo models resulted in an increased infection
and parasite burden. These findings highlight the
role of autophagy as a component of immune
responses against T. cruzi. Future studies on the
participation of autophagy at different levels of the
immunity against T. cruzi will allow understanding
the mechanisms that prevail in the establishment of
the infection, particularly in the case of the chronic
stage which is characterized by T. cruzi persistence,
tissue damage and inflammatory response.
Concluding remarks
As one of the main processes that regulate cell survival,
differentiation or death, autophagy has a major partici-
pation in the T. cruzi life-cycle. Evidence shows that
parasitic autophagy is required during the interconver-
sion between epimastigotes, trypomastigotes and amas-
tigotes. These changes confer to the parasite the
capacity to adapt to the following host in their life-
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cycle making parasite autophagy an excellent target for
trypanocidal drugs.
Host autophagy has also been described as a one of
the main regulators of T. cruzi invasion with possible
effects on the maturation of the parasitophorous
vacuole. Therefore, modulation of this process could
favor the infection control by the cell. Furthermore, the
recruitment of LC3 to the T. cruzi parasitophorous
vacuole constitutes an interesting finding that needs
to be better characterized in the future, to understand
which type of process, e.g. canonical autophagy; xeno-
phagy or even LAP are involved.
The pivotal role of autophagy in pathogenicity and
virulence demonstrated in T. cruzi suggests that autop-
hagy machinery is a possible good target for anti-parasitic
intervention. Further studies, especially using different
classes of cells, phagocytic and non-phagocytic and also
on in vivo models of infection by T. cruzi, will be man-
datory to confirm the possible beneficial effect of autop-
hagy modulation that might offer the perspective to
interfere with the infective cycle of T. cruzi in the host.
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